4 results on '"Stephanie Hartmann"'
Search Results
2. β-Secretase BACE1 Promotes Surface Expression and Function of Kv3.4 at Hippocampal Mossy Fiber Synapses
- Author
-
Giuseppina Tesco, Kerstin Voelkl, Sandra Karch, Fang Zheng, Christian Alzheimer, Carla D’Avanzo, Selene Lomoio, Doo Yeon Kim, Benedikt Zott, Michele Constanze Kyncl, Tobias Huth, and Stephanie Hartmann
- Subjects
0301 basic medicine ,Mossy fiber (hippocampus) ,Male ,Hippocampal formation ,Synapse ,03 medical and health sciences ,Mice ,0302 clinical medicine ,mental disorders ,Amyloid precursor protein ,Animals ,Aspartic Acid Endopeptidases ,Humans ,Channel blocker ,Ion channel ,Research Articles ,Cells, Cultured ,Hippocampal mossy fiber ,biology ,Chemistry ,General Neuroscience ,Cell biology ,Mice, Inbred C57BL ,Protein Transport ,030104 developmental biology ,HEK293 Cells ,Shaw Potassium Channels ,Mossy Fibers, Hippocampal ,Excitatory postsynaptic potential ,biology.protein ,Female ,Amyloid Precursor Protein Secretases ,030217 neurology & neurosurgery - Abstract
The β-secretase β-site APP-cleaving enzyme 1 (BACE1) is deemed a major culprit in Alzheimer's disease, but accumulating evidence indicates that there is more to the enzyme than driving the amyloidogenic processing of the amyloid precursor protein. For example, BACE1 has emerged as an important regulator of neuronal activity through proteolytic and, most unexpectedly, also through nonproteolytic interactions with several ion channels. Here, we identify and characterize the voltage-gated K+channel 3.4 (Kv3.4) as a new and functionally relevant interaction partner of BACE1. Kv3.4 gives rise to A-type current with fast activating and inactivating kinetics and serves to repolarize the presynaptic action potential. We found that BACE1 and Kv3.4 are highly enriched and remarkably colocalized in hippocampal mossy fibers (MFs). In BACE1−/−mice of either sex, Kv3.4 surface expression was significantly reduced in the hippocampus and, in synaptic fractions thereof, Kv3.4 was specifically diminished, whereas protein levels of other presynaptic K+channels such as KCa1.1 and KCa2.3 remained unchanged. The apparent loss of presynaptic Kv3.4 affected the strength of excitatory transmission at the MF–CA3 synapse in hippocampal slices of BACE1−/−mice when probed with the Kv3 channel blocker BDS-I. The effect of BACE1 on Kv3.4 expression and function should be bidirectional, as predicted from a heterologous expression system, in which BACE1 cotransfection produced a concomitant upregulation of Kv3.4 surface level and current based on a physical interaction between the two proteins. Our data show that, by targeting Kv3.4 to presynaptic sites, BACE1 endows the terminal with a powerful means to regulate the strength of transmitter release.SIGNIFICANCE STATEMENTThe β-secretase β-site APP-cleaving enzyme 1 (BACE1) is infamous for its crucial role in the pathogenesis of Alzheimer's disease, but its physiological functions in the intact nervous system are only gradually being unveiled. Here, we extend previous work implicating BACE1 in the expression and function of voltage-gated Na+and K+channels. Specifically, we characterize voltage-gated K+channel 3.4 (Kv3.4), a presynaptic K+channel required for action potential repolarization, as a novel interaction partner of BACE1 at the mossy fiber (MF)–CA3 synapse of the hippocampus. BACE1 promotes surface expression of Kv3.4 at MF terminals, most likely by physically associating with the channel protein in a nonenzymatic fashion. We advance the BACE1–Kv3.4 interaction as a mechanism to strengthen the temporal control over transmitter release from MF terminals.
- Published
- 2018
3. Ion channel regulation by β-secretase BACE1 – enzymatic and non-enzymatic effects beyond Alzheimer's disease
- Author
-
Sabine Hessler, Tobias Huth, Helmuth Adelsberger, Christian Alzheimer, Stephanie Hartmann, and Sandra Lehnert
- Subjects
0301 basic medicine ,Biophysics ,Hippocampus ,Review ,Voltage-Gated Sodium Channels ,Biochemistry ,Pathogenesis ,03 medical and health sciences ,0302 clinical medicine ,Alzheimer Disease ,mental disorders ,medicine ,Animals ,Aspartic Acid Endopeptidases ,Humans ,Ion channel ,chemistry.chemical_classification ,Neurons ,biology ,Sodium channel ,medicine.disease ,030104 developmental biology ,Enzyme ,Drug development ,chemistry ,Potassium Channels, Voltage-Gated ,biology.protein ,Alzheimer's disease ,Amyloid Precursor Protein Secretases ,Neuroscience ,Amyloid precursor protein secretase ,Ion Channel Gating ,030217 neurology & neurosurgery - Abstract
β-site APP-cleaving enzyme 1 (BACE1) has become infamous for its pivotal role in the pathogenesis of Alzheimer's disease (AD). Consequently, BACE1 represents a prime target in drug development. Despite its detrimental involvement in AD, it should be quite obvious that BACE1 is not primarily present in the brain to drive mental decline. In fact, additional functions have been identified. In this review, we focus on the regulation of ion channels, specifically voltage-gated sodium and KCNQ potassium channels, by BACE1. These studies provide evidence for a highly unexpected feature in the functional repertoire of BACE1. Although capable of cleaving accessory channel subunits, BACE1 exerts many of its physiologically significant effects through direct, non-enzymatic interactions with main channel subunits. We discuss how the underlying mechanisms can be conceived and develop scenarios how the regulation of ion conductances by BACE1 might shape electric activity in the intact and diseased brain and heart.
- Published
- 2016
4. beta-Secretase BACE1 Regulates Hippocampal and Reconstituted M-Currents in a beta-Subunit-Like Fashion
- Author
-
Tobias Huth, Matthias Nissen, Fang Zheng, Christian Alzheimer, Andrea Rittger, Elke Edelmann, Meike Völkel, Sabine Hessler, Paul Saftig, Sandra Lehnert, Michael Schwake, and Stephanie Hartmann
- Subjects
Male ,Nervous system ,hippocampus ,BACE1-AS ,Action Potentials ,Hippocampal formation ,Biology ,Mice ,KCNQ ,M current ,mental disorders ,Amyloid precursor protein ,medicine ,Animals ,Aspartic Acid Endopeptidases ,Humans ,Premovement neuronal activity ,M-current ,Cells, Cultured ,KCNQ Potassium Channels ,Pyramidal Cells ,General Neuroscience ,HEK 293 cells ,BACE1 ,Articles ,Alzheimer's disease ,Transmembrane protein ,Cell biology ,Protein Subunits ,HEK293 Cells ,medicine.anatomical_structure ,biology.protein ,epilepsy ,Female ,Amyloid Precursor Protein Secretases ,Neuroscience ,Protein Binding - Abstract
The β-secretase BACE1 is widely known for its pivotal role in the amyloidogenic pathway leading to Alzheimer's disease, but how its action on transmembrane proteins other than the amyloid precursor protein affects the nervous system is only beginning to be understood. We report here that BACE1 regulates neuronal excitability through an unorthodox, nonenzymatic interaction with members of the KCNQ (Kv7) family that give rise to the M-current, a noninactivating potassium current with slow kinetics. In hippocampal neurons from BACE1−/−mice, loss of M-current enhanced neuronal excitability. We relate the diminished M-current to the previously reported epileptic phenotype of BACE1-deficient mice. In HEK293T cells, BACE1 amplified reconstituted M-currents, altered their voltage dependence, accelerated activation, and slowed deactivation. Biochemical evidence strongly suggested that BACE1 physically associates with channel proteins in a β-subunit-like fashion. Our results establish BACE1 as a physiologically essential constituent of regular M-current function and elucidate a striking new feature of how BACE1 impacts on neuronal activity in the intact and diseased brain.
- Published
- 2015
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.